President & Ceo
CurrentSparrow Pharmaceuticals is a clinical stage, private biopharmaceutical company developing targeted therapeutics for serious disorders of steroid excess.
Please complete the CAPTCHA to continue
@sparrowpharma.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Jacks is listed as President & CEO at Sparrow Pharmaceuticals, Inc. at Sparrow Pharmaceuticals, Inc., based in New York City Metropolitan Area, United States, United States. AeroLeads shows a work email signal at sparrowpharma.com and a matched LinkedIn profile for Robert Jacks.
Robert Jacks previously worked as President & CEO at Sparrow Pharmaceuticals, Inc. and President & CEO at Indalo Therapeutics. Robert Jacks holds Mba, Finance from Columbia Business School.
This section adds company-level context without repeating Robert Jacks's masked contact details.
AeroLeads found 2 current-domain work email signals for Robert Jacks. Compare company email patterns before reaching out.
Biopharmaceutical industry executive with 20 years of experience focused on product development, corporate strategy, business development, fund raising, commercial analysis, finance, and operations. Multiple companies founded or co-founded. More than $150 million raised, with several successful exits.
Listed skills include Pharmaceutical Industry, Biotechnology, Strategy, Start Ups, and 33 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Portland, Oregon, US
Sparrow Pharmaceuticals is a clinical stage, private biopharmaceutical company developing targeted therapeutics for serious disorders of steroid excess.
Cambridge, MA, US
Indalo Therapeutics is a preclinical-stage biotechnology company backed by Atlas and F-Prime dedicated to improving the lives of patients suffering from debilitating fibrotic diseases.
New York, NY, US
OrbiMed is a leading healthcare focused investment firm with over $14 billion under management across public and private company investments worldwide.
Symbiomix is a late-stage biopharmaceutical company with a focus on women's health backed by OrbiMed, F-Prime, and HBM Partners. Symbiomix developed Solosec™ from pre-clinical candidate through NDA approval in less than five years before being sold to Lupin Inc. in 2017.
Professional services to the biotechnology and pharmaceutical industries in the areas of business development, fund raising, commercial analysis, valuation, and product development strategy. Clients include: Invida Pharmaceuticals, a specialty pharmaceutical company with operations across Asia Pacific; SMC Biotechnology, a private company with innovative.
South San Francisco, CA, US
Leadership Team member for private biotech with a CCR5/CCR2 antagonist in development for HIV. Led business development efforts, participated in Series B financing.
Responsible for partnering strategy and execution for venture financed oncology spin-out from Bayer Healthcare with four oral kinase inhibitor programs.
New York, New York, US
Led Licensing Leadership Teams for Infectious Diseases, Oncology and Ophthalmology. Created sourcing strategies and plans, identified and evaluated opportunities, formed and led cross-functional analysis teams, presented to management and interfaced with potential partners.
New York, New York, US
Led commercial assessment teams and early marketing strategy for Infectious Diseases and Oncology. Designed clinical development and regulatory strategies for pipeline products. Recommended target launch positioning and investment plans to create differentiation and maximize value.
Quick answers generated from the profile data available on this page.
Robert Jacks works for Sparrow Pharmaceuticals, Inc..
Robert Jacks is listed as President & CEO at Sparrow Pharmaceuticals, Inc. at Sparrow Pharmaceuticals, Inc..
AeroLeads has found 2 work email signals at @sparrowpharma.com for Robert Jacks at Sparrow Pharmaceuticals, Inc..
Robert Jacks is based in New York City Metropolitan Area, United States, United States while working with Sparrow Pharmaceuticals, Inc..
Robert Jacks has worked for Sparrow Pharmaceuticals, Inc., Indalo Therapeutics, Orbimed, Symbiomix Therapeutics, Llc, and Daristen Health, Llc.
You can use AeroLeads to view verified contact signals for Robert Jacks at Sparrow Pharmaceuticals, Inc., including work email, phone, and LinkedIn data when available.
Robert Jacks holds Mba, Finance from Columbia Business School.
Robert Jacks is listed with skills including Pharmaceutical Industry, Biotechnology, Strategy, Start Ups, Business Development, Oncology, Clinical Development, and Corporate Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts